Expression and Regulation of Osteoprotegerin in Adipose Tissue
Open Access
- 1 January 2007
- journal article
- Published by Yonsei University College of Medicine in Yonsei Medical Journal
- Vol. 48 (5) , 765-772
Abstract
An JJ, et al. Yonsei Med J. 2007 Oct;48(5):765-772. https://doi.org/10.3349/ymj.2007.48.5.765Keywords
This publication has 26 references indexed in Scilit:
- Inflammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cellsBiochemical and Biophysical Research Communications, 2005
- Osteoprotegerin and Diabetic MacroangiopathyHormone and Metabolic Research, 2005
- Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-?Diabetologia, 2005
- Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and OsteoprotegerinCirculation Research, 2004
- Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistanceJournal of Clinical Investigation, 2003
- Vascular Endothelial Growth Factor Up-regulates Expression of Receptor Activator of NF-κB (RANK) in Endothelial CellsJournal of Biological Chemistry, 2003
- Receptor Activator of NF-κB and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human OsteoclastogenesisJournal of Biological Chemistry, 2001
- Protein Expression and Functional Difference of Membrane-Bound and Soluble Receptor Activator of NF-κB Ligand: Modulation of the Expression by Osteotropic Factors and CytokinesBiochemical and Biophysical Research Communications, 2000
- Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial CellsJournal of Biological Chemistry, 2000
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998